Prognostic factors of clinical responses in patients with advanced-stage intrahepatic cholangiocarcinoma following Atractylodes lancea administration: A phase 2A clinical trial medrxiv.org/content/10.1101/20

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.